Skip to main content
NCBI home page
British Heart Journal logoLink to British Heart Journal
. 1991 Mar;65(3):137–142. doi: 10.1136/hrt.65.3.137

Influence of angiotensin converting enzyme inhibition on pump function and cardiac contractility in patients with chronic congestive heart failure.

L H Baur 1, J J Schipperheyn 1, J Baan 1, A van der Laarse 1, B Buis 1, E E van der Wall 1, V Manger Cats 1, A D van Dijk 1, J A Blokland 1, M Frölich 1, et al.
PMCID: PMC1024535  PMID: 2015121

Abstract

Eleven patients with coronary artery disease and chronic heart failure were studied before and three months after the angiotensin converting enzyme inhibitor enalapril was added to their frusemide medication. The following were measured: left ventricular pressure and volume with transient occlusion of the inferior vena cava, radionuclide angiography, and hormone concentrations in plasma. As in other reported studies, the clinical condition of the patients improved and their exercise tolerance increased moderately. Addition of enalapril reduced end diastolic and systolic pressure, reduced ventricular volume, and concomitantly increased the ejection fraction. The end systolic pressure-volume relation shifted to the left as it did in a similar animal study. In the animal study unloading by a vasodilator did not induce a leftward shift, so it can be inferred that in the present study unloading combined with a decrease in the angiotensin concentration was instrumental in remodelling the heart. Though unloading was expected to have a beneficial effect on the oxygen supply/demand ratio of the heart, the patients still showed the same drop in the ejection fraction during exercise as they did before treatment with enalapril, and early diastolic filling did not improve. Normally, regression of cardiac dilatation is only found if pump function improves; the present study showed that unloading in combination with angiotensin converting enzyme inhibition reshapes the ventricle without improving intrinsic pump function.

Full text

PDF
137

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baan J., Jong T. T., Kerkhof P. L., Moene R. J., van Dijk A. D., van der Velde E. T., Koops J. Continuous stroke volume and cardiac output from intra-ventricular dimensions obtained with impedance catheter. Cardiovasc Res. 1981 Jun;15(6):328–334. doi: 10.1093/cvr/15.6.328. [DOI] [PubMed] [Google Scholar]
  2. Baan J., van der Velde E. T., de Bruin H. G., Smeenk G. J., Koops J., van Dijk A. D., Temmerman D., Senden J., Buis B. Continuous measurement of left ventricular volume in animals and humans by conductance catheter. Circulation. 1984 Nov;70(5):812–823. doi: 10.1161/01.cir.70.5.812. [DOI] [PubMed] [Google Scholar]
  3. Dunkman W. B., Wilen M., Franciosa J. A. Enalapril (MK-421), a new angiotensin-converting enzyme inhibitor. Acute and chronic effects in heart failure. Chest. 1983 Nov;84(5):539–545. doi: 10.1378/chest.84.5.539. [DOI] [PubMed] [Google Scholar]
  4. Fitzpatrick D., Nicholls M. G., Ikram H., Espiner E. A. Haemodynamic, hormonal, and electrolyte effects of enalapril in heart failure. Br Heart J. 1983 Aug;50(2):163–169. doi: 10.1136/hrt.50.2.163. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Franciosa J. A., Wilen M. M., Jordan R. A. Effects of enalapril, a new angiotensin-converting enzyme inhibitor, in a controlled trial in heart failure. J Am Coll Cardiol. 1985 Jan;5(1):101–107. doi: 10.1016/s0735-1097(85)80090-5. [DOI] [PubMed] [Google Scholar]
  6. Freer R. J., Pappano A. J., Peach M. J., Bing K. T., McLean M. J., Vogel S., Sperelakis N. Mechanism for the postive inotropic effect of angiotensin II on isolated cardiac muscle. Circ Res. 1976 Aug;39(2):178–183. doi: 10.1161/01.res.39.2.178. [DOI] [PubMed] [Google Scholar]
  7. Jalil J. E., Doering C. W., Janicki J. S., Pick R., Shroff S. G., Weber K. T. Fibrillar collagen and myocardial stiffness in the intact hypertrophied rat left ventricle. Circ Res. 1989 Jun;64(6):1041–1050. doi: 10.1161/01.res.64.6.1041. [DOI] [PubMed] [Google Scholar]
  8. KOCH-WESER J. MYOCARDIAL ACTIONS OF ANGIOTENSIN. Circ Res. 1964 Apr;14:337–344. doi: 10.1161/01.res.14.4.337. [DOI] [PubMed] [Google Scholar]
  9. Kass D. A., Midei M., Graves W., Brinker J. A., Maughan W. L. Use of a conductance (volume) catheter and transient inferior vena caval occlusion for rapid determination of pressure-volume relationships in man. Cathet Cardiovasc Diagn. 1988;15(3):192–202. doi: 10.1002/ccd.1810150314. [DOI] [PubMed] [Google Scholar]
  10. Kass D. A., Yamazaki T., Burkhoff D., Maughan W. L., Sagawa K. Determination of left ventricular end-systolic pressure-volume relationships by the conductance (volume) catheter technique. Circulation. 1986 Mar;73(3):586–595. doi: 10.1161/01.cir.73.3.586. [DOI] [PubMed] [Google Scholar]
  11. Kobayashi M., Furukawa Y., Chiba S. Positive chronotropic and inotropic effects of angiotensin II in the dog heart. Eur J Pharmacol. 1978 Jul 1;50(1):17–25. doi: 10.1016/0014-2999(78)90249-2. [DOI] [PubMed] [Google Scholar]
  12. Kromer E. P., Riegger G. A., Liebau G., Kochsiek K. Effectiveness of converting enzyme inhibition (enalapril) for mild congestive heart failure. Am J Cardiol. 1986 Feb 15;57(6):459–462. doi: 10.1016/0002-9149(86)90772-1. [DOI] [PubMed] [Google Scholar]
  13. Levine T. B., Olivari M. T., Garberg V., Sharkey S. W., Cohn J. N. Hemodynamic and clinical response to enalapril, a long-acting converting-enzyme inhibitor, in patients with congestive heart failure. Circulation. 1984 Mar;69(3):548–553. doi: 10.1161/01.cir.69.3.548. [DOI] [PubMed] [Google Scholar]
  14. Little W. C. The left ventricular dP/dtmax-end-diastolic volume relation in closed-chest dogs. Circ Res. 1985 Jun;56(6):808–815. doi: 10.1161/01.res.56.6.808. [DOI] [PubMed] [Google Scholar]
  15. Mur G., Baan J. Computation of the input impedances of a catheter for cardiac volumetry. IEEE Trans Biomed Eng. 1984 Jun;31(6):448–453. doi: 10.1109/TBME.1984.325407. [DOI] [PubMed] [Google Scholar]
  16. Pfeffer J. M., Pfeffer M. A., Braunwald E. Influence of chronic captopril therapy on the infarcted left ventricle of the rat. Circ Res. 1985 Jul;57(1):84–95. doi: 10.1161/01.res.57.1.84. [DOI] [PubMed] [Google Scholar]
  17. Rautaharju P. M., Prineas R. J., Eifler W. J., Furberg C. D., Neaton J. D., Crow R. S., Stamler J., Cutler J. A. Prognostic value of exercise electrocardiogram in men at high risk of future coronary heart disease: Multiple Risk Factor Intervention Trial experience. J Am Coll Cardiol. 1986 Jul;8(1):1–10. doi: 10.1016/s0735-1097(86)80084-5. [DOI] [PubMed] [Google Scholar]
  18. Raya T. E., Gay R. G., Aguirre M., Goldman S. Importance of venodilatation in prevention of left ventricular dilatation after chronic large myocardial infarction in rats: a comparison of captopril and hydralazine. Circ Res. 1989 Feb;64(2):330–337. doi: 10.1161/01.res.64.2.330. [DOI] [PubMed] [Google Scholar]
  19. Sharpe D. N., Murphy J., Coxon R., Hannan S. F. Enalapril in patients with chronic heart failure: a placebo-controlled, randomized, double-blind study. Circulation. 1984 Aug;70(2):271–278. doi: 10.1161/01.cir.70.2.271. [DOI] [PubMed] [Google Scholar]
  20. Sharpe N., Murphy J., Smith H., Hannan S. Treatment of patients with symptomless left ventricular dysfunction after myocardial infarction. Lancet. 1988 Feb 6;1(8580):255–259. doi: 10.1016/s0140-6736(88)90347-9. [DOI] [PubMed] [Google Scholar]
  21. Thormann J., Kramer W., Kindler M., Kremer P., Schlepper M. Bestimmung der Wirkkomponenten von Amrinon durch kontinuierliche Analyse der Druck-Volumen-Beziehungen; Anwendung der Conductance-(Volumen-)Kathetertechnik und der schnellen Laständerung durch Ballonokklusion der Vena cava inferior. Z Kardiol. 1987 Sep;76(9):530–540. [PubMed] [Google Scholar]
  22. Weisman H. F., Bush D. E., Mannisi J. A., Weisfeldt M. L., Healy B. Cellular mechanisms of myocardial infarct expansion. Circulation. 1988 Jul;78(1):186–201. doi: 10.1161/01.cir.78.1.186. [DOI] [PubMed] [Google Scholar]
  23. Weiss J. L., Frederiksen J. W., Weisfeldt M. L. Hemodynamic determinants of the time-course of fall in canine left ventricular pressure. J Clin Invest. 1976 Sep;58(3):751–760. doi: 10.1172/JCI108522. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Xiang J. Z., Linz W., Becker H., Ganten D., Lang R. E., Schölkens B., Unger T. Effects of converting enzyme inhibitors: ramipril and enalapril on peptide action and sympathetic neurotransmission in the isolated heart. Eur J Pharmacol. 1985 Jul 17;113(2):215–223. doi: 10.1016/0014-2999(85)90738-1. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES